HYCAMTIN (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the HYCAMTIN drug offered from Novartis Pharmaceuticals Corporation. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | topotecan hydrochloride |
| SUBSTANCE NAME: | TOPOTECAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-12-21 |
| END MARKETING DATE: | 0000-00-00 |
HYCAMTIN HUMAN PRESCRIPTION DRUG Details:
| Item Description | HYCAMTIN from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(mg/4mL) |
| START MARKETING DATE: | 2016-12-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0674_112d98de-93fa-47d9-be0e-86e26671b812 |
| PRODUCT NDC: | 0078-0674 |
| APPLICATION NUMBER: | NDA020671 |
Other TOPOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
